Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-CAP for oxidative stress modulation and core symptoms in autism
IRCT20170315033086N13Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2026
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of nano carbonate apatite in Autism Spectrum Disorder (ASD), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2026; status: recruiting.
02
Drugs
nano carbonate apatite
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20170315033086N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170315033086N13.